CHC Healthcare Group (TPE:4164)
29.30
+0.55 (1.91%)
Jun 3, 2026, 1:30 PM CST
CHC Healthcare Group Market Cap
CHC Healthcare Group has a market cap or net worth of 5.72 billion as of June 3, 2026. Its market cap has decreased by -27.42% in one year.
Market Cap
5.72B
Enterprise Value
10.01B
Revenue
4.55B
Ranking
n/a
PE Ratio
27.88
Stock Price
29.30
Market Cap Chart
Since October 18, 2011, CHC Healthcare Group's market cap has decreased from 9.89B to 5.72B, a decrease of -42.15%. That is a compound annual growth rate of -3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 5.72B | -23.90% |
| Dec 31, 2025 | 7.52B | 7.82% |
| Dec 31, 2024 | 6.97B | -31.26% |
| Dec 29, 2023 | 10.15B | 44.21% |
| Dec 30, 2022 | 7.04B | 14.81% |
| Dec 30, 2021 | 6.13B | 3.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 345.61B |
| Caliway Biopharmaceuticals | 156.41B |
| Lotus Pharmaceutical | 51.25B |
| Heron Neutron Medical | 50.09B |
| Formosa Optical Technology | 5.66B |
| Mycenax Biotech | 5.63B |
| AnnJi Pharmaceutical | 5.52B |
| Orient Pharma | 5.44B |